A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Reads0
Chats0
TLDR
In this article, a 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity, and increasing scores on the scale were strongly associated with multiple domains of functional impairment.Abstract:
Background Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. Methods A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. Results A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. Conclusion The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.read more
Citations
More filters
Journal ArticleDOI
Effect of a Patient and Clinician Communication-Priming Intervention on Patient-Reported Goals-of-Care Discussions Between Patients With Serious Illness and Clinicians: A Randomized Clinical Trial.
J. Randall Curtis,Lois Downey,Anthony L. Back,Elizabeth L. Nielsen,Sudiptho Paul,Alexandria Z. Lahdya,Patsy D. Treece,Priscilla Armstrong,Ronald Peck,Ruth A. Engelberg +9 more
TL;DR: This intervention increased the occurrence, documentation, and quality of goals-of-care communication during routine outpatient visits and increased goal-concordant care at 3 months among patients with stable goals, with no change in symptoms of anxiety or depression.
Journal ArticleDOI
The Pain Course: a randomised controlled trial of a clinician-guided Internet-delivered cognitive behaviour therapy program for managing chronic pain and emotional well-being.
Blake F. Dear,Nick Titov,Kathryn Nicholson Perry,Luke Johnston,Bethany M. Wootton,Matthew D. Terides,Ronald M. Rapee,Jennifer L. Hudson +7 more
TL;DR: The results appear better than those reported in iCBT studies to date and provide support for the potential of clinician‐guided ICBT in the treatment of disability, anxiety, and depression for people with chronic pain.
Journal ArticleDOI
Sleep problems among Chinese adolescents and young adults during the coronavirus-2019 pandemic.
Shuang-Jiang Zhou,Lei-Lei Wang,Rui Yang,Xing-Jie Yang,Li-Gang Zhang,Zhao-Chang Guo,Jin-Cheng Chen,Jing-Qi Wang,Jingxu Chen +8 more
TL;DR: Results of this study revealed a high prevalence of sleep problems among adolescents and young adults during the COVID-19 epidemic, especially senior high school and college students, which were negatively associated with students’ projections of trends in CO VID-19.
Journal ArticleDOI
Caregiver Burden and Prevalence of Depression, Anxiety and Sleep Disturbances in Alzheimer's Disease Caregivers in China
Shuai Liu,Chonghui Li,Zhihong Shi,Xiao-Dan Wang,Yuying Zhou,Shuling Liu,Jing Liu,Tao Yu,Yong Ji +8 more
TL;DR: Depression, anxiety and sleep problems are the main challenges that are faced by family caregivers of patients with Alzheimer's disease, and caregivers' functional status, lower life satisfaction, depression and anxiety influenced caregiver burden.
Journal ArticleDOI
Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing.
Sara Mostafavi,Alexis Battle,Xiaowei Zhu,James B. Potash,Myrna M. Weissman,Jianxin Shi,Kenneth B. Beckman,Christian D. Haudenschild,Courtney McCormick,R Mei,Marc J. Gameroff,H Gindes,Philip Adams,Fernando S. Goes,Francis M. Mondimore,Dean F. MacKinnon,L Notes,Barbara W. Schweizer,David Furman,Stephen B. Montgomery,Alexander E. Urban,Daphne Koller,Douglas F. Levinson +22 more
TL;DR: The hypothesis that altered immune signaling has a role in the pathogenesis, manifestation, and/or the persistence and progression of MDD is supported.
References
More filters
Journal ArticleDOI
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
John E. Ware,Cathy D. Sherbourne +1 more
TL;DR: A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Journal ArticleDOI
The PHQ-9: validity of a brief depression severity measure.
TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Journal ArticleDOI
An inventory for measuring clinical anxiety: psychometric properties.
TL;DR: Un nouvel inventaire auto-administre destine a mesurer l'anxiete pathologique, le «Beck Anxiety Cheklist» (BAI) est decrit, evalue et compare au «Hamilton Anxiety Rating Scale» (test avec lequel des correlations moderees sont trouvees).
Journal ArticleDOI
The validity of the Hospital Anxiety and Depression Scale: An updated literature review
TL;DR: HADS was found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population.